Výsledky vyhledávání - "Type 2/complications"

The Changing Face of Turner Syndrome

Autor: Claus H Gravholt, Mette Viuff, Jesper Just, Kristian Sandahl, Sara Brun, Janielle van der Velden, Niels H Andersen, Anne Skakkebaek

Publikováno v: Gravholt, C H, Viuff, M, Just, J, Sandahl, K, Brun, S, van der Velden, J, Andersen, N H & Skakkebaek, A 2023, ' The Changing Face of Turner Syndrome ', Endocrine Reviews, vol. 44, no. 1, pp. 33-69 . https://doi.org/10.1210/endrev/bnac016
Gravholt, C H, Viuff, M, Just, J, Sandahl, K, Brun, S, van der Velden, J, Andersen, N H & Skakkebaek, A 2023, ' The changing face of Turner syndrome ', Endocrine reviews, vol. 44, no. 1, bnac016, pp. 33–69 . https://doi.org/10.1210/endrev/bnac016
Endocrine Reviews, 44, 33-69
Endocrine Reviews, 44, 1, pp. 33-69

Turner syndrome (TS) is a condition in females missing the second sex chromosome (45,X) or parts thereof. It is considered a rare genetic condition and is associated with a wide range of clinical stigmata, such as short stature, ovarian dysgenesis, d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a55812c0cf9d8c38207068125807c7d
https://hdl.handle.net/2066/290600

Zobrazit plný text záznamu

Autor: Cañadas-Garre, Marisa, Kunzmann, Andrew T., Anderson, Kerry, Brennan, Eoin P., Doyle, Ross, Patterson, Christopher C., Godson, Catherine, Maxwell, Alexander P., McKnight, Amy Jayne

Publikováno v: Cañadas-Garre, M, Kunzmann, A T, Anderson, K, Brennan, E P, Doyle, R, Patterson, C C, Godson, C, Maxwell, A P & McKnight, A J 2023, ' Albuminuria-related genetic biomarkers: replication and predictive evaluation in individuals with and without diabetes from the UK Biobank ', International Journal of Molecular Sciences, vol. 24, no. 13, 11209 . https://doi.org/10.3390/ijms241311209

Increased albuminuria indicates underlying glomerular pathology and is associated with worse renal disease outcomes, especially in diabetic kidney disease. Many single nucleotide polymorphisms (SNPs), associated with albuminuria, could be potentially

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2607::844c57c186c896d93a16329673de1eb8
https://pure.qub.ac.uk/en/publications/2a2d194c-05b0-4bdb-bbea-259f2d820468

Zobrazit plný text záznamu

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort

Autor: Idil Esen, Suzanne Arends, Berit Dalsgaard Nielsen, Philip Therkildsen, Ib Hansen, Anna van 't Ende, Peter Heeringa, Annemieke Boots, Ellen Hauge, Elisabeth Brouwer, Yannick van Sleen

Publikováno v: BMJ Open, 9(1). BMJ PUBLISHING GROUP
Edsen, I, Arends, S, Nielsen, B D, Therkildsen, P, Hansen, I T, Ende, A V, Heeringa, P, Boots, A, Hauge, E M, Brouwer, E & van Sleen, Y 2023, ' Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort ', RMD Open, vol. 9, no. 1, e002640 . https://doi.org/10.1136/rmdopen-2022-002640

ObjectivesGiant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are age-associated inflammatory diseases that frequently overlap. Both diseases require long-term treatment with glucocorticoids (GCs), often associated with comorbidities. Previou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95dd9974d49440854e5fab95917cba05
https://doi.org/10.1136/rmdopen-2022-002640

Zobrazit plný text záznamu

Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial

Autor: Nicole Jacqueline Jensen, Helena Zander Wodschow, Mads Juul Skytte, Amirsalar Samkani, Arne Astrup, Jan Frystyk, Bolette Hartmann, Jens Juul Holst, Thomas Meinert Larsen, Sten Madsbad, Faidon Magkos, Kamilla Woznica Miskowiak, Steen Bendix Haugaard, Thure Krarup, Jørgen Rungby, Mads Norvin Thomsen

Publikováno v: Jensen, N J, Wodschow, H Z, Skytte, M J, Samkani, A, Astrup, A, Frystyk, J, Hartmann, B, Holst, J J, Larsen, T M, Madsbad, S, Magkos, F, Miskowiak, K W, Haugaard, S B, Krarup, T, Rungby, J & Thomsen, M N 2022, ' Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial ', Clinical Nutrition, vol. 41, no. 7, pp. 1605-1612 . https://doi.org/10.1016/j.clnu.2022.05.005
Jensen, N J, Wodschow, H Z, Skytte, M J, Samkani, A, Astrup, A, Frystyk, J, Hartmann, B, Holst, J J, Larsen, T M, Madsbad, S, Magkos, F, Miskowiak, K W, Haugaard, S B, Krarup, T, Rungby, J & Thomsen, M N 2022, ' Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes : A randomised controlled trial ', Clinical Nutrition, vol. 41, no. 7, pp. 1605-1612 . https://doi.org/10.1016/j.clnu.2022.05.005

Background & aims: We evaluated the effect of weight loss induced by dietary carbohydrate restriction on health-related quality of life (HRQoL) and cognition in type 2 diabetes (T2D).Methods: In this randomised parallel trial, 72 adults with T2D and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c4999a8663583d6854b5f4baebbd84b
https://doi.org/10.1016/j.clnu.2022.05.005

Zobrazit plný text záznamu

Prolyl Carboxypeptidase Activity Is Present in Human Adipose Tissue and Is Elevated in Serum of Obese Men with Type 2 Diabetes

Autor: Emilie De Hert, Kenneth Verboven, Kristiaan Wouters, Johan W. E. Jocken, Ingrid De Meester

Publikováno v: International journal of molecular sciences, 23(21):13529. Multidisciplinary Digital Publishing Institute (MDPI)
International journal of molecular sciences
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13529

Prolyl carboxypeptidase (PRCP) is involved in metabolic disorders by hydrolyzing anorexigenic peptides. A link between serum PRCP activity and obesity has been reported, but its origin/source is still unclear. Previously proven correlations between h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65cbd427f41b9add2322f13b167533f
https://cris.maastrichtuniversity.nl/en/publications/bf16283c-4e03-4062-9b60-62f9c898c600

Zobrazit plný text záznamu

Plný text ve formátu HTML

Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit

Autor: Naomi Holman, Sarah H. Wild, Kamlesh Khunti, Peter Knighton, Jackie O’Keefe, Chirag Bakhai, Bob Young, Naveed Sattar, Jonathan Valabhji, Edward W. Gregg

Publikováno v: Holman, N, Wild, S H, Khunti, K, Knighton, P, O'Keefe, J, Bakhai, C, Young, B, Sattar, N A, Valabhji, J & Gregg, E W 2022, ' Incidence and characteristics of remission of type 2 diabetes in England : A cohort study using the National Diabetes Audit ', Diabetes Care, vol. 45, no. 5, pp. 1151-1161 . https://doi.org/10.2337/dc21-2136
Diabetes Care

OBJECTIVE To assess the incidence of remission of type 2 diabetes in routine care settings. RESEARCH DESIGN AND METHODS People with type 2 diabetes (HbA1c ≥48 mmol/mol [6.5%] or RESULTS In 2,297,700 people with type 2 diabetes, the overall incidenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cee731d3bc860a535df02fe54eb0ba1
https://doi.org/10.2337/dc21-2136

Zobrazit plný text záznamu

Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial

Autor: Siriyotha, Sukanya, Lukkunaprasit, Thitiya, Angkananard, Teeranan, Looareesuwan, Panu, McKay, Gareth J, Attia, John, Thakkinstian, Ammarin

Publikováno v: Siriyotha, S, Lukkunaprasit, T, Angkananard, T, Looareesuwan, P, McKay, G J, Attia, J & Thakkinstian, A 2023, ' Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial ', Frontiers in endocrinology, vol. 14, 1094221 . https://doi.org/10.3389/fendo.2023.1094221

IntroductionThe cardiovascular benefits of multiple antihyperglycemic drugs as add-on therapies to metformin in the real-practice are unclear. This study aimed to directly compare major adverse cardiovascular events (CVE) associated with these multip

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b8c844b1df721201c624a141da485d
https://doi.org/10.3389/fendo.2023.1094221

Zobrazit plný text záznamu

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus:a nationwide cohort study

Autor: So-Ryoung Lee, Hyo-Jeong Ahn, Eue-Keun Choi, Seung-Woo Lee, Kyung-Do Han, Seil Oh, Gregory Y. H. Lip

Publikováno v: Lee, S-R, Ahn, H-J, Choi, E-K, Lee, S-W, Han, K-D, Oh, S & Lip, G Y H 2023, ' Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus : a nationwide cohort study ', Cardiovascular Diabetology, vol. 22, no. 1, 18 . https://doi.org/10.1186/s12933-023-01749-z

Background Patients with concurrent atrial fibrillation (AF) and diabetes mellitus (DM) [AF-DM] have a high risk of cardiovascular and diabetes-related complications, but are less engaged in a comprehensive treatment approach. We evaluated the associ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70f40e20c26527cb8f86840dfc0ca9b
https://vbn.aau.dk/ws/files/516311060/Lee_et_al._2023_._Improved_prognosis_with_integrated_care_management_including_early_rhythm_control_and_healthy_lifestyle_modification_in_patients_with_concurrent_atrial_fibrillation_and_diabetes_mellitus_a_nationwide_coho.pdf

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání